IL-24 treatment did not exert any discernible impact on cell viability, but WP1066 treatment markedly inhibited the proliferation of both MDA-MB-231 and HCC-1954 cells (Fig. 6G, H). The gene discussed is IL24; the disease is hepatocellular carcinoma.